[Treatment of external RF hyperthermia combining with alpha 1-adrenergic receptor blocker for patients with prostatodynia and chronic non-bacterial prostatitis]
- PMID: 12479049
[Treatment of external RF hyperthermia combining with alpha 1-adrenergic receptor blocker for patients with prostatodynia and chronic non-bacterial prostatitis]
Abstract
Objectives: To evaluate a new effective treatment for prostatodynia (PD) and chronic non-bacterial prostatitis (CNP).
Methods: One hundred and thirty-six patients suffered from PD or CNP were divided randomly into experiment group (n = 76), which were treated with external RF hyperthermia (ERFH) combining with alpha 1-adrenergic receptor blocker Terazosin for 12 weeks, and control group (n = 60), which were only treated with ERFH. Symptoms scores, urodynamic indexes and expressed prostate secretion were recorded pre- and post-treatments.
Results: MFR and AFR were significantly improved and symptoms scores significantly decreased in both groups (P < 0.05). The efficacy was better in experiment group than that in control group. The combination treatment also led to a significantly decrease in MUP and MUCP (P < 0.05). Additionally, the leucocytes in expressed prostate secretion were also reduced in experiment group (P < 0.05).
Conclusions: Treatment of ERFH combining with alpha 1-adrenergic receptor blocker for patients with PD or CNP was effective and had little side-effect, while the future curative effect should be observed furtherly.
Similar articles
-
[Medication combined with local hyperthermia: a desirable therapy for chronic prostatitis pain symptoms].Zhonghua Nan Ke Xue. 2008 May;14(5):451-3. Zhonghua Nan Ke Xue. 2008. PMID: 18572868 Clinical Trial. Chinese.
-
Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.J Urol. 2003 Feb;169(2):592-6. doi: 10.1097/01.ju.0000042927.45683.6c. J Urol. 2003. PMID: 12544314 Clinical Trial.
-
More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study.Prostate Cancer Prostatic Dis. 2006;9(3):261-5. doi: 10.1038/sj.pcan.4500881. Epub 2006 May 9. Prostate Cancer Prostatic Dis. 2006. PMID: 16683008 Clinical Trial.
-
Role of alpha1-blockers in chronic prostatitis syndromes.BJU Int. 2008 Mar;101 Suppl 3:11-6. doi: 10.1111/j.1464-410X.2008.07496.x. BJU Int. 2008. PMID: 18307680 Review.
-
[Use of alpha 1-adrenergic antagonists in treating chronic prostatitis].Urologiia. 2003 May-Jun;(3):62-6. Urologiia. 2003. PMID: 12846104 Review. Russian. No abstract available.
Cited by
-
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2018 May 12;5(5):CD012551. doi: 10.1002/14651858.CD012551.pub3. Cochrane Database Syst Rev. 2018. PMID: 29757454 Free PMC article. Review.
-
Non-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome.Cochrane Database Syst Rev. 2018 Jan 26;1(1):CD012551. doi: 10.1002/14651858.CD012551.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2018 May 12;5:CD012551. doi: 10.1002/14651858.CD012551.pub3. PMID: 29372565 Free PMC article. Updated. Review.